What is Meridian Bioscience?
Meridian Bioscience is a comprehensive life science entity focused on the development, manufacturing, marketing, and distribution of innovative diagnostic and life science products. The company is a critical supplier of raw materials for immunological and molecular tests, catering to human, animal, plant, and environmental applications. Its product portfolio includes advanced molecular platforms, immunoassay systems, and blood chemistry tools designed to address a wide spectrum of disease areas, from gastrointestinal and respiratory illnesses to sexually transmitted and tropical diseases. Serving a global clientele of healthcare providers, research institutions, and biotech firms across more than 70 countries, Meridian Bioscience, headquartered in Cincinnati, Ohio, is committed to advancing diagnostic capabilities with solutions that prioritize speed, accuracy, and simplicity.
How much funding has Meridian Bioscience raised?
Meridian Bioscience has raised a total of $525M across 2 funding rounds:
Other Financing Round
$25M
Debt
$500M
Other Financing Round (2022): $25M, investors not publicly disclosed
Debt (2023): $500M led by Citi, J.P. Morgan Asset Management, PNC Financial Services Group Inc, Standard Chartered, Standard Chartered Bank Ghana, Industrial Bank of Korea, Kookmin Bank, and Export-Import Bank of Korea
Key Investors in Meridian Bioscience
Citi
Citi, a prominent financial services multinational, provides banking services and financial loans, indicating a role in facilitating Meridian Bioscience's debt financing.
J.P. Morgan Asset Management
J.P. Morgan Asset Management, a global leader in investment management, likely provided significant capital through its extensive portfolio and advisory services, supporting Meridian Bioscience's strategic financial objectives.
PNC Financial Services Group Inc
PNC Financial Services Group Inc, a diversified financial services company, contributed to the debt financing, highlighting its role in supporting enterprise-level capital needs for established companies in the life science sector.
What's next for Meridian Bioscience?
The recent major strategic investment in Meridian Bioscience, following a substantial debt financing round, indicates a strong financial footing and confidence from its backers. This enterprise-level funding is likely to fuel further innovation in diagnostic technologies, expansion into new markets, and potential strategic acquisitions. The company's focus on critical raw materials and diagnostic solutions positions it to capitalize on the growing global demand for advanced healthcare and life science tools, suggesting a trajectory of sustained growth and market leadership.
See full Meridian Bioscience company page
